AbbVie Exercises Right to Buy Biotech Mitokinin for Initial $110 Million
By Colin Kellaher AbbVie has exercised its exclusive right to buy discovery-stage biotechnology company Mitokinin in a deal that bolsters the biopharmaceutical company's neuroscience pipeline....